Testicular germ cell tumours.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Lancet

• Publication date

  2016-04-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0140-6736(15)00991-5PMID 26651223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.

  2015cited by this paper
• Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.

  2015cited by this paper
• Guidelines on Testicular Cancer: 2015 Update.

  2015cited by this paper
• Rare inactivating PDE11A variants associated with testicular germ cell tumors.

  2015cited by this paper
• Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.

  2015cited by this paper
• Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach.

  2015cited by this paper
• Frequent PD-L1 expression in testicular germ cell tumors

  2015cited by this paper
• Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.

  2015cited by this paper
• One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group.

  2014cited by this paper
• A nationwide cohort study of stage I seminoma patients followed on a surveillance program.

  2014cited by this paper
• Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.

  2014cited by this paper
• Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.

  2014cited by this paper
• Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.

  2014cited by this paper
• Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis

  2013cited by this paper
• Paracetamol, aspirin, and indomethacin induce endocrine disturbances in the human fetal testis capable of interfering with testicular descent.

  2013cited by this paper
• Identification of a novel androgen receptor mutation in a family with multiple components compatible with the testicular dysgenesis syndrome.

  2013cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]

  2013cited by this paper
• Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy

  2013cited by this paper
• Active surveillance is the preferred approach to clinical stage I testicular cancer.

  2013cited by this paper
• Meta-analysis identifies four new loci associated with testicular germ cell tumor

  2013cited by this paper
• Targeted serum miRNA (TSmiR) test for diagnosis and follow‐up of (testicular) germ cell cancer patients: A proof of principle

  2013cited by this paper
• Global incidence and outcome of testicular cancer

  2013cited by this paper
• Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma

  2013cited by this paper
• Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14

  2013cited by this paper
• Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4.

  2013cited by this paper
• Dysregulation of the mitosis–meiosis switch in testicular carcinoma in situ

  2013cited by this paper
• Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2013cited by this paper
• Analysis of TET Expression/Activity and 5mC Oxidation during Normal and Malignant Germ Cell Development

  2013cited by this paper
• Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

  2013cited by this paper
• Comment on ‘Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'

  2013cited by this paper
• Endocrine disruptors, gene deregulation and male germ cell tumors.

  2013cited by this paper
• Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.

  2013cited by this paper
• Congenital malformations and testicular germ cell tumors

  2013cited by this paper
• Age at puberty and risk of testicular cancer: a meta-analysis.

  2012cited by this paper
• Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

  2012cited by this paper
• Methylation profile of DNA repetitive elements in human testicular germ cell tumor

  2012cited by this paper
• Socio-economic inequalities in testicular cancer survival within two clinical studies.

  2012cited by this paper
• MicroRNA expression profiling of carcinoma in situ cells of the testis.

  2012cited by this paper
• Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.

  2012cited by this paper
• Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983.

  2012cited by this paper
• MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours

  2012cited by this paper
• Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group

  2012cited by this paper
• Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.

  2012cited by this paper
• Adolescent and adult risk factors for testicular cancer

  2012cited by this paper
• Population‐based case‐control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk

  2012cited by this paper
• Epigenetics: A way to understand the origin and biology of testicular germ cell tumors

  2012cited by this paper
• The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.

  2012cited by this paper
• Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.

  2012cited by this paper
• Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).

  2011cited by this paper
• Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?

  2011cited by this paper
• Testicular germ cell tumors: pathogenesis, diagnosis and treatment

  2011cited by this paper
• DMRT1 prevents female reprogramming in the postnatal mammalian testis

  2011cited by this paper
• Testicular biopsy for early cancer detection--objectives, technique and controversies.

  2011cited by this paper
• A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility.

  2011cited by this paper
• First-line chemotherapy

  2011cited by this paper
• Organochlorine compounds and testicular dysgenesis syndrome: human data.

  2011cited by this paper
• Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.

  2011cited by this paper
• Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculate.

  2011cited by this paper
• Salvage Chemotherapy With High-Dose Carboplatin and Etoposide With Peripheral Blood Stem Cell Transplant in Patients With Relapsed Pure Seminoma

  2011cited by this paper
• Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.

  2011cited by this paper
• A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974).

  2011cited by this paper
• Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: a large North American experience.

  2011cited by this paper
• Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.

  2011cited by this paper
• Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.

  2011cited by this paper
• The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation.

  2011cited by this paper
• The testicular germ cell tumour transcriptome.

  2011cited by this paper
• Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.

  2010cited by this paper
• Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer

  2010cited by this paper
• TNM seventh edition: What's new, what's changed

  2010cited by this paper
• Surveillance in stage I seminoma patients: a long-term assessment.

  2010cited by this paper
• A systematic review and meta-analysis of the relationship between body size and testicular cancer

  2010cited by this paper
• Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: benefit from chemotherapy, surgery, or both?

  2010cited by this paper
• Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.

  2010cited by this paper
• Testicular cancer survivorship: research strategies and recommendations.

  2010cited by this paper
• DNMT3L Is a Novel Marker and Is Essential for the Growth of Human Embryonal Carcinoma

  2010cited by this paper
• Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance

  2010cited by this paper
• Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells

  2010cited by this paper
• No role for routine chest radiography in stage I seminoma surveillance.

  2010cited by this paper
• Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2010cited by this paper
• Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer.

  2010cited by this paper
• Tumor Risk in Disorders of Sex Development

  2010cited by this paper
• Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?

  2010cited by this paper
• TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

  2010cited by this paper
• Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.

  2010cited by this paper
• Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?

  2010cited by this paper
• International Trends in the Incidence of Testicular Cancer, 1973-2002

  2010cited by this paper
• Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte.

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy.

  2009cited by this paper
• Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer

  2009cited by this paper
• A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the mother.

  2009cited by this paper
• Late relapse of nonseminomatous germ cell tumours

  2009cited by this paper
• Association of marijuana use and the incidence of testicular germ cell tumors

  2009cited by this paper
• Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography.

  2009cited by this paper
• Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.

  2009cited by this paper
• Testosterone production is better preserved after 16 than 20 Gray irradiation treatment against testicular carcinoma in situ cells.

  2009cited by this paper
• A role for Lin28 in primordial germ cell development and germ cell malignancy

  2009cited by this paper
• A genome-wide association study of testicular germ cell tumor

  2009cited by this paper

• Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models

  2026cites this paper
• Semen Cryopreservation in Testicular Cancer: Before or After Orchidectomy?

  2026cites this paper
• Risk of testicular cancer and exposure to welding fumes.

  2026cites this paper
• Temporal dynamics of Sertoli and germ cell development in human foetal and prepubertal testis.

  2026cites this paper
• Exploring the microbiome-gut-testis axis in testicular germ cell tumors

  2025cites this paper
• A Rare Cause of Massive Scrotal Elephantiasis: Case Report and Literature Review

  2025cites this paper
• High-dose chemotherapy in male germ cell cancer patients—a study by the SWENOTECA group

  2025cites this paper
• Baseline health‐related quality‐of‐life metrics among patients with testicular germ cell tumours

  2025cites this paper
• Prenatal exposure to organochlorine pesticides and polychlorinated biphenyls and risk of testicular germ cell cancer later in life.

  2025cites this paper
• Lifetime occupational and para-occupational exposure to organic solvents and testicular germ cell tumor risk: a French case-control study-TESTIS.

  2025cites this paper
• Germ cell tumours of the testis: 10-year survival data from a tertiary care centre in India

  2025cites this paper
• Single-cell analysis unravels divergent gene signatures shaping seminoma stemness and metastasis

  2025cites this paper
• Stage I Non-Seminomatous Testicular Cancer: Long-Term Follow-Up with Surveillance Approach Post-Orchiectomy

  2025cites this paper
• Salvage En Bloc Resection for Refractory Recurrent Pure Testicular Seminoma: A Case Report

  2025cites this paper
• Tumores germinales

  2025cites this paper
• Nonseminomatous mixed germ cell tumor of the testis: Case report

  2025cites this paper
• MicroRNA-371a-3p Represents a Novel and Effective Diagnostic Marker for Testicular Germ Cell Tumours: A Real-World Prospective Comparison with Conventional Approaches

  2025cites this paper
• Deep learning-based super-resolution US radiomics to differentiate testicular seminoma and non-seminoma: an international multicenter study

  2025cites this paper
• Exposure to per- and polyfluoroalkyl substances during fetal development and risk of testicular germ cell cancer in adulthood

  2025cites this paper
• Validation of the Testicular Health Outcomes Report (THOR): a testicular cancer health‐related quality of life instrument

  2025cites this paper
• Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications

  2025influential citation
• Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer at a National Referral Centre

  2025cites this paper
• Tracking and analysis of testicular cancer burden in adolescents and young adults globally in Asia and in China: 1990–2021 epidemiological trends

  2025cites this paper
• Testicular Germ Cell Tumors: A Review.

  2025cites this paper
• Racial/ethnic differences in trends of testicular germ cell tumor incidence in the United States, 1992–2021

  2025cites this paper
• Global burden and trends of testicular cancer in adolescents and young adults from 1990 to 2021, with predictions to 2035

  2024cites this paper
• Postchemotherapy Robot-Assisted Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: Initial Experience at a Brazilian Oncology Center

  2024cites this paper
• Teratoma Development in 129.MOLF-Chr19 Mice Elicits Two Waves of Immune Cell Infiltration

  2024cites this paper
• The fate of germ cells in cryptorchid testis

  2024cites this paper
• The Immune Landscape and Immunotherapeutic Strategies in Platinum-Refractory Testicular Germ Cell Tumors

  2024cites this paper
• A Unique Case of Bilateral Testicular Tumours: Nonseminomatous Germ Cell Tumour and Contralateral Spermatocytic Tumour 27 Years Apart

  2024cites this paper
• Occupational exposure to organic solvents and the risk of developing testicular germ cell tumors (TESTIS study): Effect of combined exposure assessment on risk estimation

  2024cites this paper
• Follow-up of non-palpable testicular incidentalomas under 1 cm: does growth rate differentiate malignant and non-malignant lesions?

  2024cites this paper
• Malignant ovarian and testicular germ cell tumors: Common characteristics but different prognoses

  2024cites this paper
• Multifocality in Testicular Cancer: Clinicopathological Correlations and Prognostic Implications

  2024cites this paper
• Extragonadal Germ Cell Tumors: A Clinicopathologic Study with Emphasis on Molecular Features, Clinical Outcomes and Associated Secondary Malignancies.

  2024cites this paper
• Understanding the role of endocrine disrupting chemicals in testicular germ cell cancer: Insights into molecular mechanisms.

  2024cites this paper
• Expression of CD44 is associated with aggressiveness in seminomas

  2024cites this paper
• Cryptorchidism and testicular cancer in the dog: unresolved questions and challenges in translating insights from human studies.

  2024cites this paper
• RAISN: Robot-assisted Indocyanine Green–guided Sentinel Node Biopsy in Clinical Stage I Germ Cell Tumor

  2024cites this paper
• Competing risk nomogram predicting cause-specific mortality in older patients with testicular germ cell tumors

  2024cites this paper
• Contemporary Role of Radiation Therapy in Testicular Cancer.

  2024cites this paper
• Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long‐term single centre follow‐up study

  2024cites this paper
• Parental occupations at birth and risk of adult testicular germ cell tumors in offspring: a French nationwide case–control study

  2024cites this paper
• The burden of testicular cancer from 1990 to 2019 in the Middle East and North Africa region

  2023cites this paper
• Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy

  2023cites this paper
• T cells in testicular germ cell tumors: new evidence of fundamental contributions by rare subsets

  2023cites this paper
• Silencing of LINC00467 inhibits cell proliferation in testicular germ cell tumors cells

  2023cites this paper
• Extragonadal Germ Cell Tumors: A Single Institution Experience with Clinicopathological Correlation

  2023cites this paper
• Clinical features and prognostic factors in patients diagnosed with lymphovascular invasion of testicular germ-cell tumors: Analysis based on the SEER database

  2023cites this paper
• Sonoelastography for Testicular Tumor Identification: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy

  2023cites this paper
• Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients

  2023cites this paper
• miRNAs orchestration of testicular germ cell tumors - Particular emphasis on diagnosis, progression and drug resistance.

  2023cites this paper
• Cytological spectrum of testicular malignancies with histopathological correlation: A retrospective analysis

  2023cites this paper
• No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany

  2023cites this paper
• Metastatic Testicular Cancer Patterns and Predictors: A Contemporary Population-Based SEER Analysis.

  2023cites this paper
• Parental occupational exposure to solvents and risk of developing testicular germ cell tumors among sons: a French nationwide case-control study (TESTIS study)

  2023cites this paper
• Multiparametric Ultrasound for Diagnosing Testicular Lesions: Everything You Need to Know in Daily Clinical Practice

  2023cites this paper
• Testicular germ cell tumour risk by occupation and industry: a French case–control study – TESTIS

  2023cites this paper
• Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial

  2023cites this paper
• Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours

  2023cites this paper
• Treatment de-escalation for stage II seminoma

  2023cites this paper
• CT Radiomics and Clinical Feature Model to Predict Lymph Node Metastases in Early-Stage Testicular Cancer

  2023cites this paper
• Contemporary surgical management of testicular seminoma

  2023cites this paper
• Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing

  2023cites this paper
• Treatment options in stage I seminoma

  2023cites this paper
• Subsets of preoperative sex hormones in testicular germ cell cancer: a retrospective multicenter study

  2023cites this paper
• Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders

  2023cites this paper
• Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study

  2023cites this paper
• Epidemiological Characteristics of Male Reproductive Cancers in the Republic of Kazakhstan: Ten-Year Trends

  2022cites this paper
• The Role of CT in the Staging and Follow-Up of Testicular Tumors: Baseline, Recurrence and Pitfalls

  2022cites this paper
• Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action

  2022cites this paper
• Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level

  2022cites this paper
• A Role of the TEX101 Interactome in the Common Aetiology Behind Male Subfertility and Testicular Germ Cell Tumor

  2022cites this paper
• Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk.

  2022cites this paper
• Cyst stem cell lineage eIF5 non-autonomously prevents testicular germ cell tumor formation via eIF1A/eIF2γ-mediated pre-initiation complex

  2022cites this paper
• Case - "Burned-out" testicular tumor: A rare entity with diagnostic dilemma.

  2022cites this paper
• Gastrointestinal bleeding caused by metastatic testicular choriocarcinoma: a case report and literature review

  2022cites this paper
• Varicocoele in adolescence and testicular cancer in young adulthood

  2022cites this paper
• RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma

  2022cites this paper
• Role of the Ubiquitin Ligase RNF149 in the Development of Rat Neonatal Gonocytes

  2022cites this paper
• Predicted leukocyte telomere length and risk of germ cell tumours

  2022cites this paper
• Testicular Germ Cell Tumor Composed of Seminoma and Teratoma Metastasizing as Choriocarcinoma to the Lung Successfully Treated With Salvage Chemotherapy and Bone-Marrow Transplant: A Case Report

  2022cites this paper
• Postchemotherapy retroperitoneal residual mass resection for germ cell testicular tumors: a single-center experience.

  2022cites this paper
• Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors

  2022cites this paper
• Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors

  2022cites this paper
• Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

  2022cites this paper
• The Impact of Activin A on Fetal Gonocytes: Chronic Versus Acute Exposure Outcomes

  2022cites this paper
• THE ROLE OF SPERM SEDIMENT CYTOLOGY IN NON-INVASIVE DIAGNOSTICS OF SEMINOMA. CASE REPORT

  2022cites this paper
• Burned-Out Testicular Tumor Presenting as a Retroperitoneal Mass: A Case Report

  2022cites this paper
• State Trends of Cannabis Liberalization as a Causal Driver of Increasing Testicular Cancer Rates across the USA

  2022cites this paper
• Paternal Occupational Exposure to Heavy Metals and Welding Fumes and Testicular Germ Cell Tumours in Sons in France

  2022cites this paper
• Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium

  2022cites this paper
• Deciphering Sex-Specific Differentiation of Human Fetal Gonads: Insight From Experimental Models

  2022cites this paper
• Biological functions of RNA modification patterns that define tumor microenvironment and survival outcomes in testicular germ cell tumors.

  2022cites this paper
• The seminal plasma microbiome of men with testicular germ cell tumours described by small RNA sequencing

  2022cites this paper
• Primary Mediastinal Nonseminomas: A Population-Based Surveillance, Epidemiology, and End Results Analysis.

  2021cites this paper
• Small RNAs in Seminal Plasma as Novel Biomarkers for Germ Cell Tumors

  2021cites this paper
• Causal inference multiple imputation investigation of the impact of cannabinoids and other substances on ethnic differentials in US testicular cancer incidence

  2021cites this paper
• Andrology

  2021cites this paper